| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.4 | 0.02 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.38 | 0.02 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.36 | 0.02 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |